August 25, 2020 | Blog
COVID-19 has presented an abundance of short-term implications and challenges for biopharma companies; however, it is useful to understand and prepare for the longer-term impacts as the acute disruptions to regulatory processes and healthcare delivery begin to subside. To proactively prepare for a post-COVID-19 world, biopharma leaders should develop strategies to integrate technology across the value chain and increase focus on patient centricity in terms of process flows and treatment administration.
CBPartners lists the top 10 long-term trends and implications of COVID-19 on the biopharma industry as biopharma leaders prepare for a post-COVID-19 world.
In this feature, Luke Wiggins, who works in the New York office, shares what a week in the life of an Analyst at CBPartners looks like.
The development of CBPartners’ work and culture is shaped by consultants at all levels. Entrepreneurialism thrives at the firm, with naturally curious individuals driving both internal and external initiatives. In this blog post, we caught up with Elena Subbotina to find out about her long-standing involvement with ‘The Wiki’ initiative.
Alberto Purwada, PhD describes why he wanted to become a a healthcare consultant, and speaks candidly about the challenges and appeal of the profession.